Citigroup’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.9K | Hold |
19,296
| – | – | ﹤0.01% | 5116 |
|
|
2026
Q1 | $23.9K | Hold |
19,296
| – | – | ﹤0.01% | 4773 |
|
|
2025
Q4 | $24.1K | Sell |
19,296
-1
| -0% | -$1 | ﹤0.01% | 4819 |
|
|
2025
Q3 | $27K | Buy |
19,297
+1
| +0% | +$1 | ﹤0.01% | 4710 |
|
|
2025
Q2 | $20.5K | Sell |
19,296
-14
| -0.1% | -$14 | ﹤0.01% | 5068 |
|
|
2025
Q1 | $21K | Sell |
19,310
-495,601
| -96% | -$673K | ﹤0.01% | 5080 |
|
|
2024
Q4 | $778K | Sell |
514,911
-4
| -0% | -$6 | ﹤0.01% | 3543 |
|
|
2024
Q3 | $767K | Sell |
514,915
-714
| -0.1% | -$1.1K | ﹤0.01% | 3460 |
|
|
2024
Q2 | $835K | Sell |
515,629
-7,094
| -1% | -$12.8K | ﹤0.01% | 3036 |
|
|
2024
Q1 | $889K | Buy |
522,723
+2,116
| +0.4% | +$3.95K | ﹤0.01% | 3124 |
|
|
2023
Q4 | $1.61M | Buy |
520,607
+155,043
| +42% | +$410K | ﹤0.01% | 2427 |
|
|
2023
Q3 | $2.24M | Buy |
365,564
+301,244
| +468% | +$2.07M | ﹤0.01% | 1909 |
|
|
2023
Q2 | $403K | Buy |
64,320
+6,617
| +11% | +$34.7K | ﹤0.01% | 3520 |
|
|
2023
Q1 | $275K | Sell |
57,703
-58,343
| -50% | -$411K | ﹤0.01% | 3547 |
|
|
2022
Q4 | $1.01M | Sell |
116,046
-146,864
| -56% | -$1.57M | ﹤0.01% | 2598 |
|
|
2022
Q3 | $3.13M | Sell |
262,910
-258,145
| -50% | -$3.73M | ﹤0.01% | 1824 |
|
|
2022
Q2 | $7.42M | Buy |
521,055
+493,081
| +1,763% | +$7.18M | 0.01% | 1298 |
|
|
2022
Q1 | $582K | Sell |
27,974
-70,764
| -72% | -$1.25M | ﹤0.01% | 3404 |
|
|
2021
Q4 | $2.28M | Buy |
98,738
+44,853
| +83% | +$1.08M | ﹤0.01% | 2515 |
|
|
2021
Q3 | $1.61M | Buy |
53,885
+406
| +0.8% | +$13K | ﹤0.01% | 2711 |
|
|
2021
Q2 | $1.83M | Buy |
53,479
+20,459
| +62% | +$683K | ﹤0.01% | 2729 |
|
|
2021
Q1 | $1.09M | Buy |
33,020
+30,445
| +1,182% | +$1.2M | ﹤0.01% | 2919 |
|
|
2020
Q4 | $158K | Buy |
+2,575
| New | +$101K | ﹤0.01% | 5164 |
|
Other funds holding PMVP
AWM
CIAM
Citigroup's PMVP Position: Q2 2026 in Review
Citigroup held its PMV Pharmaceuticals (PMVP) position steady in Q2 2026 at 19,296 shares worth $25.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5116.
Citigroup first reported a position in PMVP in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.42M in Q2 2022. 5 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.
- Citigroup held 19,296 shares of PMV Pharmaceuticals worth $25.9K as of Q2 2026.
- Citigroup left its PMV Pharmaceuticals share count unchanged in Q2 2026.
- PMV Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5116 holding.
- Citigroup first reported a position in PMV Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
- Citigroup's PMV Pharmaceuticals position peaked at $7.42M in Q2 2022.
- 5 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.